Confluence Life Sciences' Acquisition

Confluence Life Sciences was acquired by Aclaris Therapeutics on August 08, 2017.

Confluence Life Sciences (CLS) is developing treatments for animal and human diseases with a pipeline of programs based on kinase targets and approaches to challenging kinase targets. The company is d…

Articles about Confluence Life Sciences' Acquisition: